U.S. mortgage rates for Wednesday, Jan. 25, were up from the previous day and increased from the same time last week, according to data from Bankrate.
30-year fixed-rate loans
The average daily rate for 30-year, fixed-rate mortgages was 6.48%, up 2 basis points from 6.46% the previous day and up 9 basis points from the same day last week. (Each 1% of a mortgage rate is made up of 100 basis points.)
The refinance rate for 30-year, fixed-rate loans was 6.57%, down 1 basis point from the previous day and rising 5 basis points from the same day last week.
15-year fixed-rate loans
Mortgages with a 15-year fixed rate averaged 5.62%, a 52-week low, a decrease of 4 basis points from the prior day and declining 2 basis points from the previous week.
For jumbo loans, which cover properties that are too pricey for a conventional conforming loan (about $647,000 in most areas), the rate was 6.52%, up 1 basis point from the prior day and an increase of 13 basis points from the last week.
As for 5/1 adjustable-rate mortgages, which carry a fixed rate for five years that can then rise or fall each year after, the average was 5.37%, declining 3 basis points from the prior day and a decrease of 4 basis points from the previous week.
FHA and VA loans
The rate for 30-year, Federal Housing Administration-insured mortgages was 5.69%, down 4 basis points from the prior day and up 10 basis points from seven days prior. Mortgages backed by the Department of Veterans Affairs reached a rate of 5.86%, down 5 basis points from the previous day and a decrease of 3 basis points from the same day last week.
On a state level, Washington saw mortgage rates rise the most day over day, increasing 7 basis points to 6.46%, followed by Hawaii with a 6-basis-point increase to 6.50% and Connecticut at 6.36%, up 6 basis points.
No states posted declines in mortgage rates on Wednesday.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Bankrate.
The advice, recommendations or rankings expressed in this article are those of MarketWatch Picks, and have not been reviewed or endorsed by our commercial partners.